Market

AARTI PHARMALABS LTD.

  • NSE CodeAARTIPHARMEQ
  • BSE Code543748
  • ISININE0LRU01027
  • IndustryPharmaceuticals


Company Information

Management

Mr. Jeevan B Mondkar

Co. Secretary & Compl. Officer

Mr. Piyush Pravin Lakhani

Chief Financial Officer

Incorporation Year

22/11/2019

Registered Address


Vapi, Gujarat - 396195

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Corporate News

Aarti Pharmalabs - Trading Window

22-Dec-2025|11:41AM

Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Wi

Aarti Pharmalabs - Analysts/Institutional Investor Me...

17-Nov-2025|5:37PM

Aarti Pharmalabs Limited has informed the Exchange about Transcript

Aarti Pharmalabs - Announcement under Regulation 30 (...

17-Nov-2025|5:29PM

Transcript of Q2 FY 26 Earnings Conference Call.

Aarti Pharmalabs - Announcement under Regulation 30 (...

11-Nov-2025|6:43PM

Recording of the Earnings Conference call for Q2 FY 26

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug70.77200.66
Aarti Drug417.303,808.70
Aarti Pharma742.506,730.56
Abbott India28,905.0061,421.11
Accent Micro318.75764.65

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
HDFC Multi Ca..30.050.15
Motilal Oswal..12.300.46
ICICI Prudent..7.010.49
ICICI Prudent..7.010.49
Taurus Flexi ..5.051.38

Board Meetings

DatePurpose
09/11/2025Quarterly Results
12/08/2025Quarterly Results
10/05/2025Audited Results & F..
05/02/2025Quarterly Results, Divi..
28/10/2024Quarterly Results
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remain in investor's account.